Seal Rock To Present SRT-015 Efficacy In Cholestatic Liver Disease
30 May 2024 //
PR NEWSWIRE
Genfit licenses liver failure drug from Seal Rock in $107M deal
01 Jun 2023 //
FIERCE BIOTECH
Seal Rock Therapeutics Announces Out-Licensing Agreement with GENFIT
31 May 2023 //
PR NEWSWIRE
Seal Rock Therapeutics Announces Presentations at AASLD`s The Liver Meeting 2022
24 Oct 2022 //
PRNEWSWIRE
Seal Rock Announces Completion of Single Ascending DosePh 1 Trial of ASK1SRT-015
19 Oct 2021 //
PRNEWSWIRE
Seal Rock Announces Initiation of Phase 1 Clinical Trial of SRT-015
23 Jun 2021 //
PRNEWSWIRE